SK282277B6 - Tableta alebo kapsula na prehĺtanie a spôsob jej výroby - Google Patents

Tableta alebo kapsula na prehĺtanie a spôsob jej výroby Download PDF

Info

Publication number
SK282277B6
SK282277B6 SK1197-99A SK119799A SK282277B6 SK 282277 B6 SK282277 B6 SK 282277B6 SK 119799 A SK119799 A SK 119799A SK 282277 B6 SK282277 B6 SK 282277B6
Authority
SK
Slovakia
Prior art keywords
paracetamol
tablet
sodium bicarbonate
tablets
capsule
Prior art date
Application number
SK1197-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK119799A3 (en
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK119799A3 publication Critical patent/SK119799A3/sk
Publication of SK282277B6 publication Critical patent/SK282277B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
SK1197-99A 1997-03-05 1998-02-27 Tableta alebo kapsula na prehĺtanie a spôsob jej výroby SK282277B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition
PCT/EP1998/001284 WO1998038983A2 (fr) 1997-03-05 1998-02-27 Comprimes a avaler contenant du paracetamol

Publications (2)

Publication Number Publication Date
SK119799A3 SK119799A3 (en) 2000-02-14
SK282277B6 true SK282277B6 (sk) 2002-01-07

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1197-99A SK282277B6 (sk) 1997-03-05 1998-02-27 Tableta alebo kapsula na prehĺtanie a spôsob jej výroby

Country Status (36)

Country Link
US (1) US6316025B1 (fr)
EP (1) EP0981334B1 (fr)
JP (1) JP2001513801A (fr)
KR (1) KR100465895B1 (fr)
CN (1) CN100389751C (fr)
AP (1) AP1084A (fr)
AR (1) AR011919A1 (fr)
AT (1) ATE240720T1 (fr)
AU (1) AU721851B2 (fr)
BG (1) BG64348B1 (fr)
BR (1) BR9807992A (fr)
CA (1) CA2283408C (fr)
CO (1) CO4940406A1 (fr)
CY (1) CY2367B1 (fr)
CZ (1) CZ294078B6 (fr)
DE (1) DE69814850T2 (fr)
DK (1) DK0981334T3 (fr)
EA (1) EA001918B1 (fr)
ES (1) ES2199435T3 (fr)
GB (1) GB9704524D0 (fr)
HK (1) HK1027026A1 (fr)
HU (1) HU224983B1 (fr)
ID (1) ID22233A (fr)
IL (1) IL131552A (fr)
MY (1) MY119722A (fr)
NO (1) NO327456B1 (fr)
NZ (1) NZ337418A (fr)
PE (1) PE68899A1 (fr)
PL (1) PL190988B1 (fr)
PT (1) PT981334E (fr)
SK (1) SK282277B6 (fr)
TR (1) TR199902175T2 (fr)
TW (1) TW508242B (fr)
UA (1) UA59388C2 (fr)
WO (1) WO1998038983A2 (fr)
ZA (1) ZA981832B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
JP2006522790A (ja) * 2003-04-11 2006-10-05 ファイザー・インク エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2566331C (fr) * 2004-05-28 2011-03-15 Imaginot Pty Ltd. Systeme d'administration par voie orale
US20080287456A1 (en) 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
CN101048155A (zh) * 2004-10-28 2007-10-03 诺瓦提斯公司 含有对乙酰氨基酚、咖啡因和任选的阿司匹林以及用于增强吸收的碱性剂的组合物
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
CA2612044C (fr) * 2005-06-13 2016-02-02 Paul Rosenberg Capsule contenant un emetique
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
WO2008008120A1 (fr) * 2006-07-14 2008-01-17 Fmc Corporation Forme solide
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
EP2203165B1 (fr) 2007-08-07 2013-05-22 Stellenbosch University Paracetamol pour l'utilisation dans le traitement du glaucome
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
CA3115122A1 (fr) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Formulations de medicament resistant a l'alcool

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (fr) 1981-07-13 1985-02-05 Francis J. Sterbenz Compose d'apap et d'antiacide
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (fr) * 1989-09-01 1991-03-02 Ronald Nash Duvall Compose medicinal effervescent a teneur reduite en sodium pour le soulagement des symptomes du rhume et des allergies
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
JP2001513801A (ja) 2001-09-04
AU6828298A (en) 1998-09-22
CN100389751C (zh) 2008-05-28
PL335502A1 (en) 2000-04-25
SK119799A3 (en) 2000-02-14
CA2283408A1 (fr) 1998-09-11
AR011919A1 (es) 2000-09-13
DK0981334T3 (da) 2003-09-22
TR199902175T2 (xx) 1999-12-21
CN1253497A (zh) 2000-05-17
CZ294078B6 (cs) 2004-09-15
HUP0001501A3 (en) 2001-01-29
KR100465895B1 (ko) 2005-01-13
HUP0001501A2 (hu) 2000-09-28
US6316025B1 (en) 2001-11-13
CA2283408C (fr) 2007-01-02
EP0981334A1 (fr) 2000-03-01
PE68899A1 (es) 1999-09-26
DE69814850T2 (de) 2004-03-11
ES2199435T3 (es) 2004-02-16
UA59388C2 (uk) 2003-09-15
ID22233A (id) 1999-09-23
EA001918B1 (ru) 2001-10-22
WO1998038983A2 (fr) 1998-09-11
AP9901638A0 (en) 1999-09-30
CO4940406A1 (es) 2000-07-24
CY2367B1 (en) 2004-06-04
ATE240720T1 (de) 2003-06-15
IL131552A (en) 2004-08-31
BG103714A (en) 2000-05-31
BG64348B1 (bg) 2004-11-30
NO994294D0 (no) 1999-09-03
TW508242B (en) 2002-11-01
NZ337418A (en) 2000-05-26
KR20000075897A (ko) 2000-12-26
EA199900709A1 (ru) 2000-08-28
PL190988B1 (pl) 2006-02-28
BR9807992A (pt) 2000-03-08
HK1027026A1 (en) 2001-01-05
HU224983B1 (en) 2006-05-29
EP0981334B1 (fr) 2003-05-21
PT981334E (pt) 2003-10-31
AU721851B2 (en) 2000-07-13
WO1998038983A3 (fr) 1998-12-17
CZ314899A3 (cs) 2000-03-15
NO327456B1 (no) 2009-07-06
IL131552A0 (en) 2001-01-28
ZA981832B (en) 1998-12-11
MY119722A (en) 2005-07-29
GB9704524D0 (en) 1997-04-23
DE69814850D1 (de) 2003-06-26
AP1084A (en) 2002-07-23
NO994294L (no) 1999-09-03

Similar Documents

Publication Publication Date Title
SK282277B6 (sk) Tableta alebo kapsula na prehĺtanie a spôsob jej výroby
EP1058538B2 (fr) Comprime a desintegration rapide
US5955107A (en) Pharmaceutical suspension tablet compositions
CA2301185C (fr) Preparation pharmaceutique comprenant du clodronate en tant que principe actif et de la cellulose microcristalline silicifiee en tant qu'excipient
CZ20002391A3 (cs) Bleskově tající prostředek pro orální podání a způsob jeho výroby
JPH01250314A (ja) 徐放性製剤
EP0749308B1 (fr) Comprimes enrobes de paracetamol et de domperidone
ZA200309289B (en) Oxcarbazepine dosage forms.
US7993673B2 (en) Swallow tablet comprising paracetamol
SK281193B6 (sk) Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy
JP3836893B2 (ja) ポリカルボフィルカルシウム含有製剤
CA2653485A1 (fr) Formulations de sel de prednisolone

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: GLAXOSMITHKLINE DUNGARVAN LIMITED, DUNGARVAN, , IE

Free format text: FORMER OWNER: SMITHKLINE BEECHAM LIMITED, BRENTFORD, MIDDLESEX, GB

Effective date: 20130920

Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENT, IE

Free format text: FORMER OWNER: GLAXOSMITHKLINE DUNGARVAN LIMITED, DUNGARVAN, COUNTY WATERFORD, IE

Effective date: 20141110

TC4A Change of owner's name

Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENT, IE

Effective date: 20141110

MK4A Expiry of patent

Expiry date: 20180227